Neurol. praxi. 2014;15(1):22-25

Clinical use of SPECT in neurology

doc. MUDr. Petr Marusič, Ph.D., MUDr. Kateřina Zárubová, MUDr. Aleš Tomek
Neurologická klinika 2. LF UK a FN Motol, Praha

In neurological diagnostics, Single Photon Emission Computed Tomography (SPECT) is used only in a limited number of indications, mainly: 1) in presurgical assessment of refractory epilepsy patients, 2) in differential diagnostics of parkinsonian syndrome, 3) to assess functional cerebrovascular reserve in patients with internal carotic or intracerebral artery stenosis.

Keywords: SPECT, epilepsy, parkinsonian syndrome, cerebrovascular diseases

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marusič P, Zárubová K, Tomek A. Clinical use of SPECT in neurology. Neurol. praxi. 2014;15(1):22-25.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Benamer HT, Patterson J, Wyper DJ, Hadley DM, Macphee GJ, Grosset DG. Correlation of Parkinson s disease severity and duration with (123I) FP-CIT SPECT striatal uptake. Mov Disord 2000; 15(4): 692-698. Go to original source... Go to PubMed...
    2. Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging dopamine transporters with 123 I-FP-CIT in differentiating patients with presynaptic parkinsonism from those other forms of parkinsonism. Eur J Nucl Med 2001; 28(3): 266-272. Go to original source... Go to PubMed...
    3. Contrafatto D, Mostile G, Nicoletti A, Dibilio V, Raciti L, Lanzafame S, Luca A, Distefano A, Zappia M. [(123) I] FP-CIT-SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism. Acta Neurol Scand 2012; 126(1): 12-16. Go to original source... Go to PubMed...
    4. Desai A, Bekelis K, Thadani VM, Roberts DW, Jobst BC, Duhaime AC, Gilbert K, Darcey TM, Studholme C, Siegel A. Interictal PET and ictal subtraction SPECT: sensitivity in the detection of seizure foci in patients with medically intractable epilepsy. Epilepsia 2013; 54(2): 341-350. Go to original source... Go to PubMed...
    5. Ho SS, Berkovic SF, Berlangieri SU, Newton MR, Egan GF, Tochon-Danguy HJ, McKay WJ. Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy. Annals of Neurology 1995; 37(6): 738-745. Go to original source... Go to PubMed...
    6. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators. Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis. N Engl J Med 2011; 365(11): 993-1003. Go to original source... Go to PubMed...
    7. Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, N?gren K, Darcourt J, Tatsch K, Van Laere KJ. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging 2009; 36(12): 2093-2102. Go to original source... Go to PubMed...
    8. Kazemi NJ, Worrell GA, Stead SM, Brinkmann BH, Mullan BP, O'Brien TJ, So EL. Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology 2010; 74(1): 70-76. Go to original source... Go to PubMed...
    9. Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, Lang AE. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA and PSP. Mov Disord 2002; 17(2): 303-312. Go to original source... Go to PubMed...
    10. Kudr M, Krsek P, Marusic P, Tomasek M, Trnka J, Michalova K, Jaruskova M, Sanda J, Kyncl M, Zamecnik J, Rybar J, Jahodova A, Mohapl M, Komarek V, Tichy M. SISCOM and FDG-PET in patients with non-lesional extratemporal epilepsy: correlation with intracranial EEG, histology, and seizure outcome. Epileptic Disord 2013; 15(1): 3-13. Go to original source... Go to PubMed...
    11. Marusič P, Vojtěch Z, Brázdil M, Kršek P. Funkčně zobrazovací metody (SPECT, PET, MRS, fMRI). In: Brázdil M, Hadač J, Marusič P (Eds.). Farmakorezistentní epilepsie. Stanislav Juhaňák - Triton, 2011: 125-141.
    12. Newton MR, Berkovic SF, Austin MC, Rowe CC, McKay WJ, Bladin PF. SPECT in the localisation of extratemporal and temporal seizure foci. J Neurol Neurosurg Psychiatry 1995; 59(1): 26-30. Go to original source... Go to PubMed...
    13. Powers WJ, Clarke WR, Grubb RL Jr, Videen TO, Adams HP Jr, Derdeyn CP; COSS Investigators. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA 2011; 306(18): 1983-1992. Go to original source... Go to PubMed...
    14. Šroubek J, Kovář M, Tomek A, Plný R, Vymazal J. Extra-intrakraniální bypass při uzávěru arteria carotis interna. Neurol. pro praxi 2010; 11(1): 45-49.
    15. Van Paesschen W. Ictal SPECT. Epilepsia 2004; 45 Suppl 4: 35-40. Go to original source... Go to PubMed...
    16. Yeo JM, Lim X, Khan Z, Pal S. Systematic review of the diagnostic utility of SPECT imaging in dementia. Eur Arch Psychiatry Clin Neurosci. 2013 Aug 6. [Epub ahead of print]. Go to original source... Go to PubMed...
    17. Zárubová K, Růžička E, Roth J, Kupka K, Křížová H, Lang O, Bojar M. DaTSCAN in differential diagnosis of parkinsonian syndromes. Homeostasis 2001; 41: 144-146.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.